Inflammatix

Verified

Inflammatix develops a novel molecular diagnostics for acute infections and sepsis that work by reading the immune system. Healthcare Medical

Company News Inflammatix Team Profile Healthcare Startups Series D Route United States News

About Inflammatix

Inflammatix is tracked on 100Xfounder as a healthcare company, founded in 2016, based in San Francisco Bay Area, California, USA, currently mapped to the Series D stage. Inflammatix develops a novel molecular diagnostics for acute infections and sepsis that work by reading the immune system. Healthcare Medical

Profile snapshot: Founders linked: Inflammatix Team. Funding tracked: $102.00M. Hiring focus: Open Roles. Tech tags: Python, GCP, BigQuery, and React.

Recent signals:

Inflammatix appears in the 100Xfounder startup directory import feed.

Why it Matters

Inflammatix is worth tracking because its funding history is already mapped here, including a $102.00M round, the hiring signal points to active work across Open Roles roles, recent coverage is already tied back to this page, and Inflammatix Team's founder profile is linked directly from the company page. Use this page as the starting point before moving into the company news hub, founder profiles, and related market pages.

Funding Snapshot

Total Funding: $102.00MLast Round: Series D Khosla Ventures, $102M Series D in 2021All Rounds: 1

Series D | Khosla Ventures, $102M Series D in 2021

Hiring Roles

This company is actively hiring.

Open Roles

Meet the Founders

Inflammatix Team

Founder & CEO

Founder Profile LinkedIn

Tech Stack

PythonGCPBigQueryReact

Last updated: June 1, 2026

Inflammatix research snapshot

This page is assembled from the published company profile, linked founder directory records, and tagged newsroom context already stored on 100Xfounder. It is most useful as a quick starting point before moving into the deeper company, founder, and hub routes below.

Company summary
Inflammatix develops a novel molecular diagnostics for acute infections and sepsis that work by reading the immune system. Healthcare Medical
Founders covered
Inflammatix Team
Market position
Healthcare | Series D | San Francisco Bay Area, California, USA
Newsroom signal
No direct company-tagged stories are mapped yet; use the connected hubs below for broader market context.
Funding signal
$102.00M

Best next clicks

Company News Hub Inflammatix Team United States News Healthcare Startups Series D Funding News

Active topics

Startup News Founder Intelligence

Start with the lead founder profile if you want operator context first, then return to the company news hub for chronology.

Related Companies

Alternatives in Healthcare with comparable market signals.

Thatch

Thatch Team

View Company Industry Hub

Tempo

Tempo Team

View Company Industry Hub

Neuralink

Neuralink Team

View Company Industry Hub

Cedar

Cedar Team

View Company Industry Hub

SWORD Health

SWORD Health Team

View Company Industry Hub

Scipher Medicine

Scipher Medicine Team

View Company Industry Hub

Calibrate

Calibrate Team

View Company Industry Hub

Forward

Forward Team

View Company Industry Hub

Discover Now

Newsroom and topic pages connected to Inflammatix.

Company News Hub Topic Hubs Funding News

No company-specific newsroom stories available yet.

Contextual Research Links

Jump to country, industry, stage, startup taxonomy, and newsroom routes tied to this company.

Company profile→Founder profile→United States startup directory→Startups in United States→Healthcare hub→Healthcare startup list→Series D startup list→Series D newsroom→Healthcare startups in United States→Founder directory→

Want to get featured on 100Xfounder?

Want your company featured with founder details and funding visibility? Start here.

Contact Editorial Get Featured

FAQs About Inflammatix

Common questions people ask about this profile.

What is Inflammatix?

Inflammatix develops a novel molecular diagnostics for acute infections and sepsis that work by reading the immune system. Healthcare Medical

Who founded Inflammatix?

Inflammatix is associated with Inflammatix Team on 100Xfounder.

Where is Inflammatix located?

Inflammatix is listed in San Francisco Bay Area, California, USA.

What stage is Inflammatix in?

Inflammatix is currently mapped to Series D. Funding context: Khosla Ventures, $102M Series D in 2021

What is the latest funding round of Inflammatix?

Inflammatix's latest tracked round is Series D Khosla Ventures, $102M Series D in 2021. Total tracked rounds: 1.

Is Inflammatix hiring now?

Inflammatix hiring status: Open Roles.

What technologies does Inflammatix use?

Inflammatix is associated with Python, GCP, BigQuery, and React.

Is Inflammatix verified on 100Xfounder?

Yes. Inflammatix is currently marked verified on 100Xfounder as of June 1, 2026.

How can users connect with Inflammatix founders?

Users can move from the company page to any linked founder profiles, review the company news hub, and use listed company links when public contact routes are available.